Form 4 for OTLK Outlook Therapeutics, Inc.
Accepted 2026-08-14 19:39:28 ET · period of report 2026-08-14 · accession 0001649989-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 19:39 | 2026-08-14 | OTLK | KENYON LAWRENCE A | CFO, Dir | P - Purchase | — | +101.0K | 107.0K | +1,699% | — |
| D | 2026-08-14 19:39 | 2026-08-14 | OTLK | KENYON LAWRENCE A | CFO, Dir | P - Purchase | — | +101.0K | 101.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | P | A | 101,010 | — | 106,956 | D | — | — | (F1) On August 14, 2026, the reporting person acquired 101,010 shares of common stock and accompanying warrants to purchase 101,010 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant. |
| 2 | Derivative | Warrants (right to buy) | 2026-08-14 | P | A | 101,010 | — | 101,010 | D | $1.10 · 2026-08-14 to 2031-08-14 | 101,010 Common Stock | (F2) The warrants were exercisable immediately upon issuance and expire five years from the date of issuance, on August 14, 2031. (F1) On August 14, 2026, the reporting person acquired 101,010 shares of common stock and accompanying warrants to purchase 101,010 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant. |